
Efficient Laboratories, Inc. is voluntarily recalling 1 lot each of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAXliquid products due to microbial contamination.
Efficient Laboratories, Inc. is voluntarily recalling 1 lot each of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAXliquid products due to microbial contamination.
An Ohio law allowing pharmacists to dispense naloxone without a prescription was linked to a significant increase in naloxone dispensing rates, especially in low-employment areas.
The FDA posted results of its NDMA lab analysis of metformin products in the United States.
A supplemental application for cannabidiol oral solution (Epidiolex, GW Pharmaceuticals and Greenwich Biosciences) has been submitted for the treatment of seizures associated with tuberous sclerosis complex.
Baricitinib (Olumiant, Eli Lilly and Incyte) demonstrated positive results in the BREEZE-AD5 study of patients with atopic dermatitis.
A Publix Pharmacy under construction at a hospital in Daytona Beach, Florida, will help Publix Super Markets continue its expansion into the hospital pharmacy realm.
Eli Lilly’s lasmiditan (Reyvow) C-V 50 mg and 100 mg for the acute treatment of migraine is now available for prescription.
The FDA is requesting that manufacturers of bacitracin for injection voluntarily withdraw their product.
Quick intervention can reduce duration and severity of shingles.
Seqirus’ influenza A (H5N1) monovalent vaccine, adjuvanted (Audenz) is the first-ever adjuvanted, cell-based vaccine to protect against pandemic influenza A (H5N1).
A New Jersey law passed in mid-January requires pharmacies to provide drug disposal options and to educate their customers on how to safely dispose of unused, unwanted, or expired medications.
Peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia, Aimmune) is the first approved treatment for patients with peanut allergy.
See how some students have opted for a unique conclusion to their studies.
SGLT2 inhibitor therapy provided protective effects from cardiovascular (CV) events in patients with type 2 diabetes with or without established CV disease.
Eli Lilly plans to donate at least 200,000 KwikPens of its insulin to support lower-income communities.
WHO declares the 2019 novel coronavirus outbreak a global emergency as first person-to-person transmission occurs in US.
Amlodipine lowered the risk of gout when compared with 2 other antihypertensive medications.
OptumRx’s most recent pipeline outlook for 2020 reveals key therapeutic areas in the lineup.
Officials with the FDA have approved ferric derisomaltose (Monoferric, Pharmacosmos Therapeutics Inc.) injection 100 mg/mL.
A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.
Alkermes is seeking FDA approval for its investigational antipsychotic drug candidate ALKS 3831 for schizophrenia and bipolar I disorder.
Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.
How the pharmacy team at Novant Health Brunswick Medical Center ensured patients got their medications during Hurricane Florence.
If approved, dupilumab (Dupixent, Regeneron and Sanofi) would be indicated for use as an add-on maintenance treatment for children ages 6 to 11 years with moderate-to-severe atopic dermatitis.
Ticagrelor (Brilinta, AstraZeneca) reduced the risk of stroke and death when taken with aspirin compared with aspirin alone.
Administration time for warfarin did not affect the stability of the drug’s anticoagulation effect, a new study showed.
Fidaxomicin (Dificid, Merck) is indicated in adults and pediatric patients aged 6 months and older for the treatment of Clostridioides difficile-associated diarrhea.
In comments submitted to CMS, the pharmacy associations recommended removing barriers that limit pharmacists’ scope of practice.
The 2019 Novel Coronavirus outbreak in Wuhan City, China has caused concern as 2 cases have been recently reported in the United States.
Evidence-based recommendations focus on immunomodulators, biologics, and small molecules for the management of ulcerative colitis.